Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $62.06 million. The enterprise value is -$72.14 million.

Market Cap	62.06M
Enterprise Value	-72.14M

Important Dates

The last earnings date was Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Adicet Bio has 82.71 million shares outstanding. The number of shares has increased by 74.50% in one year.

Current Share Class	82.71M
Shares Outstanding	82.71M
Shares Change (YoY)	+74.50%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	43.95%
Float	61.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.38
P/TBV Ratio	0.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.34, with a Debt / Equity ratio of 0.10.

Current Ratio	9.34
Quick Ratio	9.15
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-63,314.50

Financial Efficiency

Return on equity (ROE) is -55.83% and return on invested capital (ROIC) is -34.67%.

Return on Equity (ROE)	-55.83%
Return on Assets (ROA)	-32.68%
Return on Invested Capital (ROIC)	-34.67%
Return on Capital Employed (ROCE)	-72.43%
Revenue Per Employee	n/a
Profits Per Employee	-$771,842
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.41% in the last 52 weeks. The beta is 1.66, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.66
52-Week Price Change	-46.41%
50-Day Moving Average	0.66
200-Day Moving Average	0.99
Relative Strength Index (RSI)	52.74
Average Volume (20 Days)	512,328

Short Selling Information

The latest short interest is 3.13 million, so 3.78% of the outstanding shares have been sold short.

Short Interest	3.13M
Short Previous Month	2.37M
Short % of Shares Out	3.78%
Short % of Float	5.09%
Short Ratio (days to cover)	4.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-126.63M
Pretax Income	-139.79M
Net Income	-117.32M
EBITDA	-120.13M
EBIT	-126.63M
Earnings Per Share (EPS)	-$1.29

Full Income Statement

Balance Sheet

The company has $150.44 million in cash and $16.25 million in debt, giving a net cash position of $134.19 million or $1.62 per share.

Cash & Cash Equivalents	150.44M
Total Debt	16.25M
Net Cash	134.19M
Net Cash Per Share	$1.62
Equity (Book Value)	161.45M
Book Value Per Share	1.95
Working Capital	137.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$94.93 million and capital expenditures -$2.37 million, giving a free cash flow of -$97.30 million.

Operating Cash Flow	-94.93M
Capital Expenditures	-2.37M
Free Cash Flow	-97.30M
FCF Per Share	-$1.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.50%
Shareholder Yield	-74.50%
Earnings Yield	-189.05%
FCF Yield	-156.79%

Dividend Details

Analyst Forecast

The average price target for Adicet Bio is $6.00, which is 699.68% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	699.68%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-37.97%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1